Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
53 hedge funds and large institutions have $16.7M invested in Biostage, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.01M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.76M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.74M |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$1.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.04M |
Top Sellers
BSTG Hedge Fund Activity: Q4 2013 in Review
53 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2013, worth a combined $16.7M.
Buyers outnumbered sellers: 53 funds opened new BSTG positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock Institutional Trust, opening a new position worth an estimated $2.01M.
- 53 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2013, up from 0 in Q3 2013.
- Funds reported $16.7M of Biostage, Inc. Common Stock stock for Q4 2013.
- 53 funds opened new Biostage, Inc. Common Stock positions in Q4 2013 and 0 closed out, a net change of +53 holders.
- The largest Biostage, Inc. Common Stock buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $2.01M added.
Based on aggregated 13F filings for Q4 2013.